Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification. [electronic resource]
- Investigational new drugs Dec 2010
- 812-24 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural